Literature DB >> 10053194

A pH-dependent colon targeted oral drug delivery system using methacrylic acid copolymers. I. Manipulation Of drug release using Eudragit L100-55 and Eudragit S100 combinations.

M Z Khan1, Z Prebeg, N Kurjaković.   

Abstract

Lactose-based placebo tablets were coated using various combinations of two methacrylic acid copolymers, Eudragit L100-55 and Eudragit S100, by spraying from aqueous systems. The Eudragit L100-55-Eudragit S100 combinations (w/w) studied were 1:0, 4:1, 3:2, 1:1, 2:3, 1:4, 1:5 and 0:1. The coated tablets were tested in vitro for their suitability for pH dependent colon targeted oral drug delivery. The same coating formulations were then applied on tablets containing mesalazine as a model drug and evaluated for in vitro dissolution rates under various conditions. The disintegration data obtained from the placebo tablets demonstrate that disintegration rate of the studied tablets is dependent on: (i) the polymer combination used to coat the tablets, (ii) pH of the disintegration media, and (iii) the coating level of the tablets. Dissolution studies performed on the mesalazine tablets further confirmed that the release profiles of the drug could be manipulated by changing the Eudragit L100-55 and Eudragit S100 ratios within the pH range of 5.5 to 7.0 in which the individual polymers are soluble respectively, and a coating formulation consisting of a combination of the two copolymers can overcome the issue of high gastrointestinal (GI) pH variability among individuals. The results also demonstrated that a combination of Eudragit L100-55 and Eudragit S100 can be successfully used from aqueous system to coat tablets for colon targeted delivery of drugs and the formulation can be adjusted to deliver drug at any other desirable site of the intestinal region of the GI tract on the basis of pH-variability. For colon targeted delivery of drugs the proposed combination system is superior to tablets coated with either Eudragit L100-55 or Eudragit S100 alone.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10053194     DOI: 10.1016/s0168-3659(98)00151-5

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  38 in total

1.  Silicone adhesive matrix of verapamil hydrochloride to provide pH-independent sustained release.

Authors:  Gaurav Tolia; S Kevin Li
Journal:  AAPS PharmSciTech       Date:  2014-02       Impact factor: 3.246

Review 2.  Tree gum-based renewable materials: Sustainable applications in nanotechnology, biomedical and environmental fields.

Authors:  Vinod V T Padil; Stanisław Wacławek; Miroslav Černík; Rajender S Varma
Journal:  Biotechnol Adv       Date:  2018-08-27       Impact factor: 14.227

3.  Development of pH-sensitive pectinate/alginate microspheres for colon drug delivery.

Authors:  Fu-Yin Hsu; Ding-Syuan Yu; Chun-Chiang Huang
Journal:  J Mater Sci Mater Med       Date:  2012-10-27       Impact factor: 3.896

4.  Effect of Kollidon® SR on the release of Albuterol Sulphate from matrix tablets.

Authors:  Walid Sakr; Fars Alanazi; Adel Sakr
Journal:  Saudi Pharm J       Date:  2010-11-04       Impact factor: 4.330

5.  Design and evaluation of matrix base with sigmoidal release profile for colon-specific delivery using a combination of Eudragit and non-ionic cellulose ether polymers.

Authors:  Laila Fatima Ali Asghar; Sajeev Chandran
Journal:  Drug Deliv Transl Res       Date:  2011-04       Impact factor: 4.617

Review 6.  Current Advances in Black Phosphorus-Based Drug Delivery Systems for Cancer Therapy.

Authors:  Wenxin Liu; Alideertu Dong; Bing Wang; Han Zhang
Journal:  Adv Sci (Weinh)       Date:  2021-01-15       Impact factor: 16.806

Review 7.  Novel Nanoprinting for Oral Delivery of Poorly Soluble Drugs.

Authors:  Cihan Yilmaz; Can Sarisozen; Vladimir Torchilin; Ahmed Busnaina
Journal:  Methodist Debakey Cardiovasc J       Date:  2016-09

8.  Gastrointestinal synthetic epithelial linings.

Authors:  Junwei Li; Thomas Wang; Ameya R Kirtane; Yunhua Shi; Alexis Jones; Zaina Moussa; Aaron Lopes; Joy Collins; Siddartha M Tamang; Kaitlyn Hess; Rameen Shakur; Paramesh Karandikar; Jung Seung Lee; Hen-Wei Huang; Alison Hayward; Giovanni Traverso
Journal:  Sci Transl Med       Date:  2020-08-26       Impact factor: 17.956

9.  eRapa restores a normal life span in a FAP mouse model.

Authors:  Paul Hasty; Carolina B Livi; Sherry G Dodds; Diane Jones; Randy Strong; Martin Javors; Kathleen E Fischer; Lauren Sloane; Kruthi Murthy; Gene Hubbard; Lishi Sun; Vincent Hurez; Tyler J Curiel; Zelton Dave Sharp
Journal:  Cancer Prev Res (Phila)       Date:  2013-11-26

10.  In vitro evaluation of dissolution behavior for a colon-specific drug delivery system (CODES) in multi-pH media using United States Pharmacopeia apparatus II and III.

Authors:  Jinhe Li; Libo Yang; Sheila M Ferguson; Tom J Hudson; Shunsuke Watanabe; Masataka Katsuma; Joseph A Fix
Journal:  AAPS PharmSciTech       Date:  2002       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.